// Articles

4 Questions with Steve Ferry of NeuroVASx Medical, a gBETA Medtech Company

Tags: , , , , , , , , , , , , , , ,

gener8tor, a nationally ranked accelerator program, has partnered with Boston Scientific to launch a healthcare-focused program in Medical Alley. Over the next few weeks, we will profile the first cohort of companies.

 

Steve Ferry (Founder and CEO) is educated in engineering and chemistry. Prior to establishing his consulting business, Endeavor Medical Technology, he worked for large companies such as Honeywell, Pfizer/American Medical Systems, mid-stage, and start-up companies. He has extensive experience in product development, project/ team management, and taking medical devices from concept to market.

What does NeuroVASx do?

Develop neurovascular access devices and therapies for aneurysms and stroke.

How does it make a difference in healthcare? 

Improved patient outcomes as well as reduced complications and cost.

What motivated you to take on this issue? 

The need for improvement of an antiquated treatment for cerebral aneurysms and stroke.

Why gBETA? 

Our company chose gBETA because of the commitment of the gBETA team to ensure that companies come out of the program with a strong leg-up when it comes to moving the company forward.

 

gBETA Medtech is a free, seven-week accelerator that works with medical device, healthcare-related software, biotech and diagnostics startups. Part of gener8tor, a nationally ranked accelerator program, gBETA Medtech is in partnership with Boston Scientific and supported by the Mayo Clinic and the University of Minnesota. For more information visit https://www.gbetamedtech.com/

 

Read Other Interviews with gBeta Participants

4 Questions with Meghan Sharkus of ExpressionMed

4 Questions with Brian Krohn of Soundly

4 Questions with Bharat Pulgam of Vitrose Health

4 Questions with Bryce Beverlin II of Quench Medical

 

 

 

 

 

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER